openPR Logo
Press release

Diabetes Management Using Glucose Monitoring Devices | TechSci Research

12-01-2021 07:06 AM CET | Health & Medicine

Press release from: TechSci Research LLC

Glucose Monitoring Devices - TechSci Research

Glucose Monitoring Devices - TechSci Research

According to the World Health Organization statistics, currently approx. 463 million people are living with diabetes throughout the world. The number is set to rise to some 700 million by 2045. Diabetes is one of the leading causes of death globally, accounting for more than 79,000 deaths annually. The growing prevalence of diabetes worldwide due to poor lifestyle, inadequate physical activity, stress, obesity, smoking, and other factors are increasing the need for new diagnostic tools and treatments to keep the insulin levels in check. Monitoring blood sugar levels is an integral part of diabetes management. With the increasing incidences of diabetes, many biotech companies are coming up with innovations for patients to check their insulin and take necessary steps conveniently.

Blood Sugar Lancing Device
Despite significant technological advancements, fingerpick blood sugar tests remain the no.1 choice for people who have diabetes. The lancing device requires pricking finger with a small, sharp needle, which have to be put up on a test strip. The strip then needs to be put into a meter that displays the sugar levels within a few seconds. The lancing devices are highly sophisticated and portable so that patients can carry the device anywhere at any time.

The new glucometers available in the market enable patients to test sites other than fingertips such as the upper arm, forearm, base of the thumb, and thigh. However, since blood sugar levels in the fingertips show changes more quickly, patients with the symptoms of hypoglycaemia should use fingertips for more accurate readings. The patients can take the fingerpick test anytime when they feel their blood sugar levels are low. With glucometers, patients need to keep records of their blood monitoring results to check for patterns, which the caregivers can utilize to check how their body reacts to certain foods, exercise, or medicines.

Continuous Glucose Monitoring Systems
In the last few years, many technologies have been introduced in the market that allow non-invasive painless blood glucose monitoring. Continuous glucose monitoring (CGMs) devices are amongst the recent advances in diabetes management technologies designed to provide patients with real-time information about glucose levels in the body. People with Type 1 and Type 2 diabetes have the option to easily manage their chronic condition by easily tracking the insulin levels that go up and down.

Since many factors come into play when it comes to fluctuating glucose levels, such as the kind of food you eat, sports you play and your overall lifestyle, sometimes healthcare providers are unable to find out the body's reaction to certain things. However, continuous glucose monitoring is equipped with a sensor that detects the blood sugar levels in the fluid under the skin over time while the patient is wearing the device. The patient can obtain glucose readings as frequently as desired using a reader or smartphone with great convenience in a painless manner. CGMs can record glucose levels throughout 24 hours and show glucose patterns over two weeks, which patients, as well as caregivers, can access.

The continuous glucose monitoring device requires the sensor to be attached to a transmitter held on the skin with a sticky patch. The sensor wirelessly transmits data to a small recording device (or a smartphone), which the patients can easily carry in their clothing, purse, bag, etc. The patients have the flexibility to remove the sensor and replace it on a different part of the body every 7 to 14 days. The implantable sensors can last up to 90 days, but they need to be re-inserted and removed by the physician or other care provider. The real-time CGM devices automatically display blood glucose levels every five minutes, and the receiver also triggers the alarm when they reach a level above or below a preset level.

Here are some of the Latest Continuous Glucose Monitoring Devices Changing the Lives of People Suffering from Diabetic Conditions

Dexcom G6
Dexcom G6 runs on a new algorithm that enhances the accuracy of the sensors and reduces the lag time between the sensor level and blood glucose levels compared to its previous models. Patients can trust the device to provide reading accurate enough to dose insulin without calibrations. Besides, the CGM device has a pain-free insertion and enables customizable alerts.

Keeps the patients informed about their glucose levels
Readings are not affected by acetaminophen
The device is covered by Medicare
Approved for all the users above the age of 2
Transmitter lasts up to 3 months

Sensors need to be changed every ten days
Require up to 2 hours of warm uptime
Sensors are not reusable

Abbott's FreeStyle Libre
Approved in 2017, FreeStyle Libre was the first continuous glucose monitor that does not require finger pricks. The sensor of the CGM device has to be worn on the back of your upper arm and lasts up to 14 days. The CGM device can store glucose readings for up to 90 days, and the sensor can store data for up to 8 hours.

Does not require calibrations
Warmup time of one hour
Can be used with the reader
Allows sharing of data with caregivers
Can be used with a reader or a smartphone

Reader needs to be changed every seven days
Does not have alerts or alarms
High levels of aspirin and vitamin can interfere with readings
Only approved for users above the age of 18

Medtronic Guardian Sensor 3
Medtronic’s insulin pumps, and continuous glucose monitoring devices are available with 670G integration with an approved sensor for seven days. The device enables customizable alerts for different times and days. The smartphone-compatible device can be used without an insulin pump and does not require a separate receiver to connect with your smartphone. The CGM device has a different transmitter attached to each sensor, but rechargeable and lasts for a year.

Includes predictive alarms for blood sugar is too high or low
Can be connected with both Android and iPhone apps
Cans share your glucose data
Can be easily inserted with a one-button insertion device
Displays past glucose data and patterns

Requires fingerstick calibrations
Requires 2-hour warmup period
Sensors cannot be reused

Eversense Continuous Glucose Monitoring Device
Eversense implantable CGM device is the first glucose sensor available in the size of a small twig, which is implanted under the skin for up to 90 days for monitoring the glucose readings in real-time. Unlike other CGMs in the market, Eversense provides glucose monitoring for up to 90 days and comes with a removable and rechargeable smart transmitter.

On-body vibration alerts for very low or high sugar levels
Chargeable and water-resistant transmitters
FDA-approved for dosing decisions
Lasts up to 90 days under the skin

Require two-finger calibrations per day
Removing and adhering to the transmitter takes at least 10 minutes every day
Not yet approved for children’s use

Upcoming Developments in Diabetes Management Therapy
People living with diabetes have to face the brunt of injecting insulin which can be painful and tiring. Now, many drug manufacturers are developing insulin pills that can be credible alternatives to insulin injection as the patient does not have to bear the pain of injections for insulin administration, essential to maintain adequate blood sugar levels for people with diabetes.

Insulin is a complex protein that degrades in the stomach and small intestine, making the insulin pills introduced earlier unsuccessful for diabetes management. However, now many manufacturers are developing insulin pills that reach directly to the liver, where it releases the hormone that mimics endogenous insulin's action. Insulin pills could make diabetes management quite convenient and affordable, eliminating the pain of needles and reducing healthcare expenditure for the patients. Leading pharmaceutical companies are using protein engineering to develop the insulin pill so that it can navigate the stomach without breaking down. Currently, only two insulin pills developed by Oramed and HDV-1 have been approved by the FDA for administration. In addition, other insulin delivery methods are also under development to make insulin administration painless and relatively inexpensive than pumps.

More and more technologies are marking an entry into the market to help people manage diabetes properly. Future therapies such as new drugs, islet cell transplantation, artificial pancreas, electronic skin patch and digital contact lenses are anticipated to improve diabetes management for type-1 and type-2 diabetes patients. Besides, many wireless glucometers are being introduced for patients to perform effective glucose monitoring.

About TechSci Research:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
For More Market Research Blogs Visit:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Management Using Glucose Monitoring Devices | TechSci Research here

News-ID: 2480506 • Views: 169

More Releases from TechSci Research LLC

United States Medical Aesthetic Devices Market to Grow with an Impressive CAGR u …
Technological advancement is driving the growth of United States Medical Aesthetic Devices Market, in the forecast period. According to TechSci report on, “United States Medical Aesthetic Devices Market By Type of Device (Energy-Based Aesthetic Device {Laser-Based Aesthetic Device, Radiofrequency-Based Aesthetic Device, Light-Based Aesthetic Device, Others} v/s Non-Energy-Based Aesthetic Device {Aesthetic Botulinum Toxin, Microdermabrasion, Implants, Others}) By Application (Skin Resurfacing and Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Facial Aesthetic Procedures,
Lithotripsy Devices Market to Grow with Double Digit CAGR During the Forecast Pe …
Rising cases of kidney stones is driving the growth in Global Lithotripsy Devices Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Lithotripsy Devices Market By Type (Intracorporeal Lithotripsy, Extracorporeal Shock Wave Lithotripsy (ESWL)) By Modality (Standalone v/s Portable) By Application (Kidney Stone, Pancreatic Stones, Ureteral Stones, Bile Duct Stone) By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the
Anesthesia Monitoring Devices Market to Grow with an Impressive CAGR During the …
Advancing technology in medicine is driving the growth in Global Anesthesia Monitoring Devices Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Anesthesia Monitoring Devices Market By Product Type (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstation) By End User (Hospitals & Surgical Centers, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the global anesthesia monitoring devices market is expected to show a robust
Why are Major Conglomerates Suddenly Splitting Up into New Corporate Entities? | …
There has been a crazy new trend of ginormous global companies dismantling into multiple entities as diversification isn’t a rage in the corporate world. Companies like Johnson & Johnson, GE, Pfizer, Merck, GlaxoSmithKline have recently announced their corporate divorces, but the splits are not confined to the healthcare sector. Many tech giants, global retail brands, telecom companies have spun off large divisions so that they can invest their time and

All 5 Releases

More Releases for CGM

Continuous Glucose Monitoring (CGM) Devices Market Potential Growth 2021
The integration of smartphone for easy diabetes management and cloud based data storage are the key features of the currently available CGM devices which have contributed to the drastic adoption of the CGM systems. The CGM devices displays a complete picture of glucose trends with a graphical display and customizable alerts to indicate the disturbances in glucose status. The major factors driving growth of the continuous glucose monitoring (CGM) devices market
Global BGM and CGM Market Data Statistics Analysis 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the BGM and CGM industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on BGM and CGM and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Global BGM and CGM Market Overview: The global BGM and CGM market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH.  Its latest research report,
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
Canada Insulin Pump & CGM Industry 2018
Canada Insulin Pump & CGM Industry Although Canada insulin pump market is small but it has market potential to reach nearly CAD 1 Billion mark by the end of year 2024. Similarly CGM market is also small but if it gets reimbursement under Canadian government then it has market potential to surpass CAD 80 Million by 2024. The government of Canada has expanded its diabetes management policy along with diabetes technology which will
Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, …
Researchmoz added Most up-to-date research on "Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast" to its huge collection of research reports. Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2
CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmi …
Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2 components: glucose sensors and CGM transmitters. Transmitters & receivers along with sensors are known as standalone CGM systems, which are preinstalled by manufacturer. Sensors are disposable items, which is replaced after